Higher risk of platelet engraftment failure and chronic graft‐versus‐host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T‐cell therapy compared to chemotherapy: A propensity score‐matched analysis
British Journal of Haematology · 2025
DOI: 10.1111/bjh.20180 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Luxin Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Immunotherapy, Adoptive, Blood Platelets. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) has been reported to further sustain long‐term leukaemia‐free survival following chimeric antigen receptor T‐cell (CAR‐T) therapy. It remains unclear whether bridging CAR‐T to allo‐HSCT results in higher treatment‐related toxicity and mortality. We conducted a retrospective study to compare outcomes between allo‐HSCT after CAR‐T or conventional chemotherapy. After propensity score matching, 62 patients with prior CAR‐T therapy and 124 patients with chemotherapy were ultimately included. Patients in the CAR‐T cohort had a longer duration time from diagnosis to transplant ( p < 0.001) and more advanced disease status before HSCT ( p < 0.001) than that of the chemotherapy cohort. Patients with prior CAR‐T cell therapy had a lower 28‐day platelet engraftment rates [Hazard Rate (HR) = 1.38, 95% Confidence Interval (CI), 1.02–1.87, p = 0.037]. Multivariate analysis revealed that CAR‐T therapy increased the risk of moderate to severe chronic graft‐versus‐host disease (cGVHD) (HR = 2.5, 95% CI, 1.01–6.19, p = 0.048). Compared with patients in the chemotherapy cohort, those in the CAR‐T cell cohort experienced a higher incidence of transplantation‐associated thrombotic microangiopathy (6.5% vs. 0.8%, p = 0.03) and probable/possible invasive fungal disease (10.0% vs. 3.3%, p = 0.08). The relapse rate, non‐relapse mortality, and survival were comparable between cohorts. Caution should be exercised in allo‐HSCT following CAR‐T therapy because of the higher risk of platelet engraftment failure and cGVHD compared to chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.
- Institute of Hematology, Zhejiang University, Hangzhou, China.
- Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, L., Lai, X., Liu, L., Shi, J., Zhao, Y., Yu, J., Wu, Y., Fu, H., Hu, Y., Zhang, M., Huang, H., & Luo, Y. (2025). Higher risk of platelet engraftment failure and chronic graft‐versus‐host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T‐cell therapy compared to chemotherapy: A propensity score‐matched analysis. British Journal of Haematology. https://doi.org/10.1111/bjh.20180
Vancouver
Yang L, Lai X, Liu L, Shi J, Zhao Y, Yu J, et al. Higher risk of platelet engraftment failure and chronic graft‐versus‐host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T‐cell therapy compared to chemotherapy: A propensity score‐matched analysis. British Journal of Haematology. 2025. doi:10.1111/bjh.20180
BibTeX
@article{Yang2025,
author = {Yang, Luxin and Lai, Xiaoyu and Liu, Lizhen and Shi, Jimin and Zhao, Yanmin and Yu, Jian and Wu, Yibo and Fu, Huarui and Hu, Yongxian and Zhang, Mingming and Huang, He and Luo, Yi},
title = {Higher risk of platelet engraftment failure and chronic graft‐versus‐host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T‐cell therapy compared to chemotherapy: A propensity score‐matched analysis},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.20180}
}
EUVIMED